期刊文献+

丙型肝炎患者基因分型与干扰素治疗疗效分析 被引量:1

Genotyping of hepatitis C patients and Efficacy of the interferon treatment
下载PDF
导出
摘要 目的讨本地区丙型肝炎病毒基因型与干扰素疗效的关系。方法156例慢性丙型肝炎(CHC)患者,HCVRNA采用荧光定量PCR试剂盒,RFLP分析进行HCV基因分型,57例慢性丙型肝炎患者采用IFN—alb治疗,疗程24周。全自动生化分析仪检测血清ALT。结果156例抗HCV阳性患者HCVRNA检出率82.05%(128/156),HCVⅠ型、Ⅱ型、Ⅲ型、Ⅳ型、Ⅱ+Ⅲ型分别为0、21.15%、55.13%、0,5.78%。干扰素治疗病例中,HCVⅡ型、Ⅲ型、Ⅱ+Ⅲ型感染的应答率分别为28.95%、53.33%、25.00%,有显著性差异(P〈0.05)。HCV基因型与血清ALT水平无相关性。结论鲁北地区HCV感染以Ⅱ、Ⅲ型感染为主,干扰素对HCVⅢ型感染的疗效优于HCVⅡ型,ALT与HCVRNA水平可作为干扰素疗效的参考指标,HCV基因分型有预测干扰素疗效的意义。 Objective Investigating the relationship between the hepatitis C virus genotypes and efficacy of the interferon trcatment in the region. Methods 156 cases of chronic hepatitis C (CHC) patients, HCV RNA using quantitative PCR kit, the analysis of RFLP is HCV genotyping, 57 chronic hepatitis C patients were treated by the treatment of IFN - alb for 24 weeks. Analyze serum ALT by automatic biochemical. Results The HCV RNA detection rate of 156 cases of anti - HCV - positive patients is 82.05% (128/156), HCV group Ⅰ , groupⅡ , group Ⅲ, gropⅣ, group Ⅱ + Ⅲ were 0, 21.15%, 55.13%, 0, 5.78%. The response rate of cases of HCV groupⅡ, groupⅢ, group Ⅱ + Ⅲ which were treated by infection were 28.95%, 53.33% and 25.00%, also have a significant difference (P 〈0.05). HCV genotype and serum ALT levels were not related. Conclusion HCV infection were group Ⅱ and Ⅲ mainly in the region of northern Shandong Province, the interferon on HCV Ⅲ infection is more effective than HCV Ⅱ group, ALT and HCV RNA levels can be used as reference to interferon therapy, HCV genotyping has predicted significance factors for interference Clinical.
作者 孙长华
出处 《医学检验与临床》 2010年第3期75-76,共2页 Medical Laboratory Science and Clinics
关键词 丙型肝炎 基因分型 干扰素 疗效 Hepatitis C virus Genotyping Interferon Efficacy
  • 相关文献

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部